drugset / Trial / NCT01764230

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

NCT01764230

Non-randomizedParallel-groupOpen-labelSupportive care

Summary

Chemotherapy as one of the basic modalities of oncology treatment often leaves permanent implications and among the most common is infertility as a result of irreversible gonadal damage. This project sets the primary target to verify the protective effect GnRH analogues administration to protect ovarian tissue during three different regimens of chemotherapy in patients with Hodgkin disease (HD) in reproductive age.

Timeline

Start
2004-01
Primary completion
2007-07
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 3 mg Intramuscular

Indications